M-CPP and Fenfluramine in Cocaine Addicts - 3

Phase 2

Completed

• Conditions: Cocaine-Related Disorders

• Registration Number: NCT00000314
• Lead Sponsor: National Institute on Drug Abuse (NIDA)

Brief Summary

The purpose of this study is to evaluate predictive value of M-CPP and fenfluramine challenges for outcome.

Detailed Description

Not available

Study Timeline

• Study Start: 1994-09
• Primary Completion: 1999-08
• Study Completion: 1999-08
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Status Verified: 2002-12
• Last Update Submitted: 2017-01-17
• Last Update Posted: 2017-01-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hospitalization, arrests, jail, employment, psychiataric symptoms
Drug use

Trial Locations

Locations (1)

VA Medical Center; 🇺🇸 Brooklyn, New York, United States